Clinical Assistant Professor, Ophthalmology and Visual Sciences, University of Maryland School of Medicine
Ophthalmology
Dr. Raymond N. Sjaarda, MD
|
|
Give Review
Raymond Sjaarda practices Ophthalmology. He graduated from Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 1 awards: "Fellow (FAAO)". Dr. Raymond N. Sjaarda is a published doctor. He has 30 papers published. The most current publication "Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Patterns of referral of retinal patients for low vision intervention in the anti-VEGF era.
- Vitrectomy for the treatment of subMacular hemorrhages from Macular degeneration: a comparison of subMacular hemorrhage/membrane removal and subMacular tissue plasmino...
- Results of Macular hole surgery with and without epiretinal dissection or internal limiting membrane removal.
- Macular hole surgery in high myopia.
- Results of Macular hole surgery in patients over 80 years of age.
- Surgical treatment of Macular holes with multiple recurrences.
- Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for Macular hole surgery.
- The results of vitreous surgery for chronic Macular holes.
- Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.
- Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic Macular holes.
- Full-thickness Macular hole formation in eyes with a pre-existing complete posterior vitreous detachment.
- Distribution of iatrogenic retinal breaks in Macular hole surgery.
- Reoperation after failed Macular hole surgery.
- Intraocular tamponade duration and success of Macular hole surgery.
- Increased intraocular pressure after Macular hole surgery.
- Efficacy of fluid-air exchange during pars plana vitrectomy.
- The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness Macular holes.
- Assessment of vision in idiopathic Macular holes with Macular microperimetry using the scanning laser ophthalmoscope.
- Resolution of an absolute scotoma and improvement of relative scotomata after successful Macular hole surgery.
- Indocyanine green angiography in multiple evanescent white-dot syndrome.
- Retreatment of full-thickness Macular holes persisting after prior vitrectomy. A pilot study.
- Fluorescein angiographic characteristics of Macular holes before and after vitrectomy with transforming growth factor beta-2.
- Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding Macular holes. Preliminary anatomic results of ...
- Effects of intraocular bubble duration in the treatment of Macular holes by vitrectomy and transforming growth factor-beta 2.
- Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for Macular holes.
- The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoRetinopathy.
- Fundus photographic and fluorescein angiographic characteristics of pseudoholes of the macula in eyes with epiretinal Membranes.
- Transforming growth factor-beta 2 for the treatment of full-thickness Macular holes. A prospective randomized study.
- Reduction of intraocular pressure with anecortave acetate in Eyes with ocular steroid injection-related glaucoma.
Schools
Duke University
Baylor
Retina Center At St Joseph Hospital
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Ocular Prosthetics
- Repair of Retinal Detachment or Retinal Tear
- View All
Conditions Treated
- Acute Endophthalmitis
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Fellow (FAAO)
Education
-
Baylor College of Medicine -
Duke University School of Medicine
Hospital
-
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1811968407 | |
| NPPES Provider LastName | SJAARDA | |
| NPPES Provider FirstName | RAYMOND | |
| NPPES Provider ZIPCode | 212046831 | |
| NPPES Provider State | MD | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 224.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811968407 |
| Last Name Of The Provider | SJAARDA |
| First Name Of The Provider | RAYMOND |
| View All |
Similar Doctors
|
|
Dr. Blonie W. Dudney Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard T. Scholz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet S. Sunness, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gary H. Cassel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley J. Amernick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay D. Goel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Collins, MD |
|
|
Dr. Katherine Duncan, MD |